Direct	212 336 8186
Main	212 336 8000
Fax	212 336 8001

 

Andrew earned a Ph.D. in Microbiology from New York University School of Medicine, where his studies focused on DNA recombination and repair pathways in microbial pathogens.

Andrew’s later post-doctoral research work at Duke University included design and development of next-generation sequencing techniques to investigate translation regulation during the cellular stress response. While at Duke, Andrew also worked as a Technology Transfer Fellow in the Office of Licensing and Ventures.

Andrew assists clients with the preparation and prosecution of patent applications relating to biotechnology and pharmaceutical inventions, including targeted gene-editing techniques, enzyme engineering, biologics and antibodies, sequencing methods and diagnostic biomarkers.

In The Press

• The Trademark Lawyer Features the Arrival of Lawyers and Other Colleagues from Cooper & Dunham
   
  
  
• Amster Rothstein & Ebenstein Expands Practice with Addition of Group from Cooper & Dunham
   
  
  

Education

• New York University, B.A., Biochemistry, 2009
• New York University, Sackler Institute of Biomedical Sciences, Ph.D., Microbiology, 2015

Honor’s & Awards

• National Institutes of Health - F31 Predoctoral Individual National Research Service Award (NRSA), “The Mechanism of Genetic Exchange in Trichomonas vaginalis” Principal Investigator, NIH Grant No. 5F31AI102596-02.